Gossamer Bio, Inc.
GOSS· Nasdaq
GOSSGossamer Bio, Inc.
Filed May 6, 2021 · 10-Q · 36 days after period end · 0001728117-21-000056
| Metric | Q1 2021 | Q1 2020 | Q1 2019 | Q1 2018 |
|---|---|---|---|---|
| Net Income | -$57.64M | -$54.07M | -$32.61M | -$26.04M |
| EPS Diluted | -$0.78 | -$0.87 | -$0.90 | -$4.31 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Gossamer Bio, Inc. · CIK 1728117 · Engraved from SEC EDGAR
ended Mar 31, 2021 · filed May 6, 2021 · 36 d after period end
